Skip to main content
. 2019 Jul 11;2019:2909632. doi: 10.1155/2019/2909632

Table 5.

Signal transduction pathways of acupuncture in treating Alzheimer's disease.

Subjects Location Acupoint Intervention Time of intervention Signal pathway Main results Author, reference
Male, SD rat, scopolamine injection brain GV20 MA pretreatment for 5 min, QD for 14 days enhance cholinergic system-CREB-BDNF pathway elevation of choline acetyltransferase, choline transporter 1, vesicular acetylcholine transporter, BDNF, CREB proteins
neuroprotection
Lee B, et al. 2014[135]

APP/PS1 mice brain GV20 EA, 1/20 Hz 30min, QD for 4 weeks modulation of BDNF-TrkB pathway elevation of BDNF/proBDNF ratio, p-TrkB
depression of β-amyloid (1-42), p75
anti-apoptosis
Lin R, et al. 2016[136]

Male, SAMP10 hippocampus CV17, CV12, CV6, ST36, SP10 MA QD regulation of aging gene elevation of p53, Mad related protein 2, Nucleoside diphosphate kinase B, AT motif-binding factor, Hsp84, Hsp86
depression of p38 MAPK, retinoblastoma-associated protein 1
anti-oxidation
Ding X, et al. 2006[18]

SD rat, Aβ1-40 injection hippocampus, frontal cortex GV20, KI3, ST36 EA, 1mA, 2Hz 15min, QD for 12 days inactivation of p38 MAPK pathway depression of p-p38 MAPK protein, IL-1beta mRNA
decrease neuroinflammation
Fang JQ, et al. 2013[137]

Male, SD rat, Aβ1-40 injection hippocampus CA1 GV20, BL23 EA, 2mA, 2-4V, 2Hz 20min, QD, 6 days/ wk for 4 weeks activation of PPAR-γ pathway elevation of PPAR-γ
depression of p-p38MAPK, Aβ, p-Tau Ser404 protein
decrease neuroinflammation
Zhang M, et al. 2017[138]

SAMP 10 mice neocortex and hippocampus CV17, CV12, CV6, SP10, ST36 not mentioned QD for 14 days p 130 pathway elevation of p130
cell proliferation
Liu T, et al. 2008[139]

Male, SAMP8 mice cortex and hippocampus CV17, CV12, CV6, ST36, SP10 MA, >2Hz 30sec per acupoint, QD, 21 days regulation of G protein/ IP3/ Ca2+ amplitude pathway elevation of physiologically coupled activation rate and maximal coupled activation rate of Gαs and Gαi
signal homeostasis
Luo B, et al. 2017[140]

Male, APP/PS1 mice brain GV20 EA, 1mA, 2/15Hz 30min, QD, 5 days/wk for 4 weeks suppression of astrocytic NDRG2 pathway depression of Glial fibrillary acidic protein, NDRG2
increase astrocytic reactivity
Wang F, et al. 2014[141]

telomerase-deficient mice(TERC-/-) mice hippocampus and dentate gyrus ST36 MA 30 min, QD for 4 days activation of BDNF pathway elevation of BDNF, TrkB, p75NTR, Akt, and ERK1/2
increase telomerase activity
Lin D, et al. 2015[142]

SD rat, beta-amyloid (Abeta)(1-40) injection hippocampal LI20, EX-HN3 EA, 1-3mA, 80-100Hz 10min, QD, 5 days/wk for 6 weeks regulation of Bcl-2/Bax elevation of Bcl-2
depression of Bax
anti-apoptosis
Liu ZB, et al. 2011[143]

Male, SD rat, Aβ1-40 injection hippocampus CA1 GV20, BL23 EA, <2mA, 20Hz 30 min, QD, 6 days/ wk for 4 weeks downregulation of Notch pathway elevation of Bcl-2, synapsin-1, synaptophysin
depression of Bax, Notch1 mRNA, Hes1 mRNA
anti-apoptosis
Guo HD, et al. 2015[144]

Male, APP/PS1 mice hippocampus GV20, KI1 EA, 1mA, 2/100Hz 15min, QD for 3 days inactivation of caspase-3/ Bax pathway elevation of Bcl-2/Bax ratio
depression of caspase-3-positive cell number and Bax protein
anti-apoptosis
Li XY, et al. 2016[145]

APP/PS1 mice hippocampus, cortex GV20 EA, 1/20Hz 30min, QD, 5 days/wk for 4 weeks regulation of AMPK/mTOR pathway elevation of GLUT1, GLUT3, p-AMPK, p-Akt, mTOR
decrease Aβ (1-42) deposition, decrease autophagy process
Liu W, et al. 2017[148]

Male, SAMP8 mice hippocampus CA1 GV14, BL23 EA, 1mA, 2Hz 20min, QD, 8 days' treatment and 2 days' rest for 3 cycles activation of AMPK pathway elevation of p-AMPK
balance energy metabolism and improved cognitive impairment
Dong W, et al. 2015[20]

Male, SAMP8 mice hippocampus and frontal cortex GV14, BL23 EA, 1mA, 2Hz 20min, QD, 8 days' treatment and 2 days' rest for 3 cycles activation of SIRT1-dependent PGC-1α expression pathway elevation of ATP levels, SIRT1, PGC-1α
depression of PGC-1α acetylation
improved brain energy metabolism
Dong W, et al. 2015[151]

Abbreviations

Akt: protein kinase B; AMPK: AMP-activated protein kinase; APP/PS1: amyloid precursor protein (APP)/presenilin-1 (PS1) double transgenic; Bax: Bcl-2 associated X; Bcl-2: B-cell lymphoma 2; BDNF: brain-derived neurotrophic factor; CREB: phosphorylated cyclic AMP response element-binding protein; EA: electroacupuncture; ERK: extracellular signal-regulated kinase; GLUT: glucose transporter; IL: interleukin; IP3: Inositol triphosphate; MA: manual acupuncture; MAPK: mitogen-activated protein kinases; NDRG2: N-myc downregulated gene 2; NMDA: N-methyl-D-aspartate; PGC1: proliferator-activated receptor γ coactivator 1; PPAR-γ: peroxisome proliferator-activated receptors γ; QD: daily; QOD: every other day; RBL2: Retinoblastoma-like protein 2; SAMP: senescence-accelerated mouse prone; SD rat: Sprague Dawley rat; SIRT1: sirtuin 1; TrkB: tyrosine receptor kinase B.